52 related articles for article (PubMed ID: 12666146)
1. Plasma chitotriosidase activity in patients with beta-thalassemia.
Barone R; Malaguarnera L; Angius A; Musumeci S
Am J Hematol; 2003 Apr; 72(4):285-6. PubMed ID: 12666146
[No Abstract] [Full Text] [Related]
2. Effect of interferon-gamma, interleukin-10, lipopolysaccharide and tumor necrosis factor-alpha on chitotriosidase synthesis in human macrophages.
Di Rosa M; Musumeci M; Scuto A; Musumeci S; Malaguarnera L
Clin Chem Lab Med; 2005; 43(5):499-502. PubMed ID: 15899671
[TBL] [Abstract][Full Text] [Related]
3. Plasma chitotriosidase activity in beta-thalassemia major: a comparative study between Sicilian and Sardinian patients.
Barone R; Bertrand G; Simporè J; Malaguarnera M; Musumeci S
Clin Chim Acta; 2001 Apr; 306(1-2):91-6. PubMed ID: 11282098
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages.
Malaguarnera L; Musumeci M; Di Rosa M; Scuto A; Musumeci S
J Clin Lab Anal; 2005; 19(3):128-32. PubMed ID: 15900564
[TBL] [Abstract][Full Text] [Related]
5. Plasma chitotriosidase activity in patients with beta-thalassemia.
Altarescu G; Rudensky B; Abrahamov A; Goldfarb A; Rund D; Zimran A; Elstein D
Am J Hematol; 2002 Sep; 71(1):7-10. PubMed ID: 12221666
[TBL] [Abstract][Full Text] [Related]
6. Plasma chitotriosidase activity is a marker of recovery in transplanted patients affected by beta-thalassemia major.
Maccarone C; Pizzarelli G; Barone R; Musumeci S
Acta Haematol; 2001; 105(2):109-10. PubMed ID: 11408716
[No Abstract] [Full Text] [Related]
7. Plasma chitotriosidase activity in patients with beta-thalassemia.
Barone R; Di Gregorio F; Romeo MA; Schilirò G; Pavone L
Blood Cells Mol Dis; 1999 Feb; 25(1):1-8. PubMed ID: 10349508
[TBL] [Abstract][Full Text] [Related]
8. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition.
Park JM; Greten FR; Li ZW; Karin M
Science; 2002 Sep; 297(5589):2048-51. PubMed ID: 12202685
[TBL] [Abstract][Full Text] [Related]
9. Chitotriosidase in multiple sclerosis.
Sotgiu S; Musumeci S
Clin Immunol; 2009 Nov; 133(2):282-3; author reply 284. PubMed ID: 19647492
[No Abstract] [Full Text] [Related]
10. The human chitotriosidase gene. Nature of inherited enzyme deficiency.
Boot RG; Renkema GH; Verhoek M; Strijland A; Bliek J; de Meulemeester TM; Mannens MM; Aerts JM
J Biol Chem; 1998 Oct; 273(40):25680-5. PubMed ID: 9748235
[TBL] [Abstract][Full Text] [Related]
11. Modulation of chitotriosidase during macrophage differentiation.
Di Rosa M; Malaguarnera G; De Gregorio C; D'Amico F; Mazzarino MC; Malaguarnera L
Cell Biochem Biophys; 2013 Jun; 66(2):239-47. PubMed ID: 23152091
[TBL] [Abstract][Full Text] [Related]
12. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
Wadsworth SA; Cavender DE; Beers SA; Lalan P; Schafer PH; Malloy EA; Wu W; Fahmy B; Olini GC; Davis JE; Pellegrino-Gensey JL; Wachter MP; Siekierka JJ
J Pharmacol Exp Ther; 1999 Nov; 291(2):680-7. PubMed ID: 10525088
[TBL] [Abstract][Full Text] [Related]
13. Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes.
Scheller C; Sopper S; Ehrhardt C; Flory E; Chen P; Koutsilieri E; Ludwig S; ter Meulen V; Jassoy C
Eur J Immunol; 2002 Sep; 32(9):2471-80. PubMed ID: 12207331
[TBL] [Abstract][Full Text] [Related]
14. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
[TBL] [Abstract][Full Text] [Related]
15. Leishmania initially activates but subsequently down-regulates intracellular mitogen-activated protein kinases and nuclear factor-kappaB signaling in macrophages.
Ben-Othman R; Guizani-Tabbane L; Dellagi K
Mol Immunol; 2008 Jun; 45(11):3222-9. PubMed ID: 18406464
[TBL] [Abstract][Full Text] [Related]
16. Chitotriosidase deficiency in Brazil: evaluation of enzyme activity and genotypes.
Rodrigues MD; Muller KB; Pereira VG; Martins AM; D'Almeida V
Blood Cells Mol Dis; 2010 Apr; 44(4):305-6. PubMed ID: 20178893
[No Abstract] [Full Text] [Related]
17. Differential regulation of indoleamine 2,3-dioxygenase expression by nitric oxide and inflammatory mediators in IFN-gamma-activated murine macrophages and microglial cells.
Alberati-Giani D; Malherbe P; Ricciardi-Castagnoli P; Köhler C; Denis-Donini S; Cesura AM
J Immunol; 1997 Jul; 159(1):419-26. PubMed ID: 9200481
[TBL] [Abstract][Full Text] [Related]
18. Involvement of tyrosine kinase and protein kinase C in the induction of nitric oxide synthase by lipopolysaccharide and interferon-gamma in J774 macrophages.
Eason S; Martin W
Arch Int Pharmacodyn Ther; 1995; 330(2):225-40. PubMed ID: 8861714
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages.
Sibley LD; Adams LB; Fukutomi Y; Krahenbuhl JL
J Immunol; 1991 Oct; 147(7):2340-5. PubMed ID: 1918966
[TBL] [Abstract][Full Text] [Related]
20. Biochemical events accompanying macrophage activation and the inhibition of colony-stimulating factor-1-induced macrophage proliferation by tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Vairo G; Royston AK; Hamilton JA
J Cell Physiol; 1992 Jun; 151(3):630-41. PubMed ID: 1338337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
